[1]刘慧慧,唐路军,胡国恒,等.名中医王行宽基于“阳化气，阴成形”治疗冠心病经验[J].陕西中医,2026,(8):1104-1107.[doi:DOI:10.3969/j.issn.1000-7369.2026.08.017]
　LIU Huihui,TANG Lujun,HU Guoheng,et al.Experience of renowned traditional Chinese medicine practitioner WANG Xingkuan in treating coronary heart disease based on principle of Yang Huaqi，Yin Chengxing[J].,2026,(8):1104-1107.[doi:DOI:10.3969/j.issn.1000-7369.2026.08.017]
点击复制

名中医王行宽基于“阳化气，阴成形”治疗冠心病经验

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2026年8期
页码:
1104-1107
栏目:
名中医经验
出版日期:
2026-08-05

文章信息/Info

Title:
Experience of renowned traditional Chinese medicine practitioner WANG Xingkuan in treating coronary heart disease based on principle of Yang Huaqi，Yin Chengxing
作者:
刘慧慧1; 唐路军2; 胡国恒3; 刘建和3; 王行宽3; WOH Tzen Ye4（马来西亚）
（1.湖南中医药大学第二附属医院，湖南 长沙 410005；2.湖南航天医院，湖南 长沙 410205；3.湖南中医药大学第一附属医院，湖南 长沙 410007；4.英迪国际大学，马来西亚 森美兰 71800）
Author(s):
LIU Huihui1; TANG Lujun2; HU Guoheng3; LIU Jianhe3; WANG Xingkuan3;  WOH Tzen Ye4
（1.The Second Hospital of Hunan University of Chinese Medicine,Changsha 410005,China；2.Hunan Aerospace Hospital,Changsha 410205,China；3.The First Hospital of Hunan University of Chinese Medicine,Changsha 410007,China；4.Inti International University, Negeri Sembilan 71800, Malaysia)
关键词:
冠心病; 胸痹; 阳化气; 阴成形; 王行宽
Keywords:
Coronary heart disease; Chest impediment; Yang Huaqi; Yin Chengxing; WANG Xingkuan
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7369.2026.08.017
文献标志码:
A
摘要:
本研究对名中医王行宽基于“阳化气，阴成形”理论治疗冠心病的临床经验进行总结。王行宽教授基于中医理论中的“阳化气，阴成形”治疗胸痹，提出“阳化气，阴成形”功能失调在胸痹发病中起重要作用，因“阳化气”不足，从而导致“阴成形”太过，形成痰浊、瘀血等病理产物，病机以心之气营亏虚、阳气不足为本，瘀血、痰浊互结为病证之标。王行宽教授认为，胸痹应重视调节阴阳之间对立统一和互根互用的协调平衡，即恢复“阳化气”不足和“阴成形”太过的失衡。“阳化气”功能正常，机体气血津液得以正常运行和输布，不易形成瘀血、痰浊等病邪。胸痹在治疗上应以补心之气营、温阳化气治其本，祛痰化瘀治其标，恢复机体“阳化气，阴成形”的动态平衡。王行宽教授根据胸痹的病机特点，创制经验方心痛灵Ⅲ号方加减。全方通补兼施，标本兼顾，共奏补益气营，温阳化气，祛痰化瘀，宽胸散结之效，诸药合用，补“阳化气”不足，消“阴成形”太过，达阴平阳秘作用。
Abstract:
This study summarizes clinical experience of renowned traditional Chinese medicine physician WANG Xingkuan in treating coronary heart disease based on theory of Yang Huaqi，Yin Chengxing.Professor WANG Xingkuan,guided by TCM principle that Yang Huaqi，Yin Chengxing proposes that dysfunction in this mechanism plays a crucial role in pathogenesis of chest obstruction (Xiong bi).Insufficiency of Yang Huaqi leads to excessive Yin Chengxing resulting in pathological products such as phlegm-dampness and blood stasis.The fundamental pathology lies in deficiency of Qiying,along with insufficient Yang energy,while manifestation was characterized by intermingled blood stasis and phlegm-dampness.Professor WANG emphasizes importance of regulating the balanced coordination and mutual dependence between Yin and Yang specifically restoring the imbalance caused by inadequate Yang Huaqi and excessive Yin Chengxing.When function of Yang Huaqi was normal,Qi,blood,and body fluids circulate and distribute properly,preventing the formation of pathogenic factors like blood stasis and phlegm-dampness.In treatment,the root should be addressed by tonifying heart Qi and Ying,warming Yang,and promoting Qi transformation,while the symptoms were resolved through eliminating phlegm and resolving blood stasis,thereby restoring the dynamic balance of Yang Huaqi，Yin Chengxing.Based on the pathogenic characteristics of chest obstruction,professor WANG developed an empirical formula,modified Xintong Ling No.Ⅲ,which combines tonification and dispersion,addressing both root and branch.This formula effectively nourishes Qi and Ying,warms Yang,transforms Qi,resolves phlegm,dispels blood stasis,relieves chest tightness,and dissolves nodules.Through synergistic action of its ingredients,it replenishes deficient Yang Huaqi，Yin Chengxing achieving the state of balanced Yin and secreted Yang.

参考文献/References:

[1]VIRANI S S,ALONSO A,APARICIO H J,et al.Heart disease and stroke statistics-2021 update:A report from the american heart association[J].Circulation,2021,143(8):e254-e743.
[2]胡盛寿,王增武.《中国心血管健康与疾病报告2022》概述[J].中国心血管病研究,2023,21(7):577-600.
[3]DU J,WU W,ZHU B,et al.Recent advances in regulating lipid metabolism to prevent coronary heart disease[J].Chem Phys Lipids,2023,255:105325.
[4]TAN J,GU J.The multifaceted role of angiopoietin-like proteins in coronary heart disease:From molecular mechanisms to clinical translation[J].J Cardiovasc Pharmacol,2026,87(5):324-336.
[5]ZHANG Q Y,LIU H X.Insights into the role of FGF21 in coronary heart disease[J].Int J Biol Macromol,2024,282(5):136911.
[6]许明良,冯蓓蓓,谭波,等.中医药治疗冠心病的现代研究进展[J].中国合理用药探索,2023,20(11):131-136.
[7]陈家祥,赵一桐,王月华,等.传统中医药在冠心病治疗中的作用[J].吉林医药学院学报,2023,44(3):221-223，227.
[8]白洋,车方远,易文慧,等.加载口服中成药对PCI术后长期主要不良心脑血管事件影响的Meta分析[J].中医杂志,2018,59(12):1024-1030.
[9]王俊岩,郑思成,何信用,等.益气活血化瘀祛痰法治疗冠心病心绞痛疗效的Meta分析[J].中华中医药学刊,2018,36(11):2647-2650.
[10]林煜坤,陈佳慧,李廷杰,等.冠心病中医病机与辨治研究进展[J].陕西中医,2024,45(11):1579-1581.
[11]王若冲,于清茜,王伟航,等.冠心病的中医认识及治疗探析[J].中医研究,2023,36(10):1-6.
[12]张曦,曹林姚,孙宇,等.基于“五辨”思维论治冠心病[J].实用心脑肺血管病杂志,2026,34(6):89-92.
[13]张学娅,饶宇东,郭春霞,等.《内经》“阳化气,阴成形”含义探讨[J].辽宁中医杂志,2020,47(4):80-82.
[14]刘玉良.感悟《黄帝内经》“阳化气,阴成形”[J].中华中医药杂志,2016,31(12):5185-5187.
[15]张伟,唐农.基于“阳化气、阴成形”探讨中风的中医证治[J].中医杂志,2020,61(8):721-723.
[16]仲东生,林建国,李成,等.基于“阳化气，阴成形”理论探讨益气活血法在冠心病治疗中的应用[J].中医学报,2024,39(1):17-21.
[17]张宜帆,周曼丽,刘培,等.从“阳化气，阴成形”理论浅析冠心病证治机理[J].中医药信息,2022,39(7):45-48.
[18]刁雅静,宋鲁成.基于“阳化气，阴成形”理论探讨冠心病证治[J].中国中医急症,2020,29(1):159-161.
[19]李正富.对“阳化气,阴成形”含义的探讨[J].浙江中医学院学报,2004,28(6):10.
[20]谭雨晴,李军,陈恒文.基于“阳化气，阴成形”论扶阳活血法在冠心病的运用[J].中国中医基础医学杂志,2022,28(6):986-988，1008.
[21]李文京,王革生.基于“阳化气，阴成形”探析冠心病之因机证治[J].江苏中医药,2025,57(7):20-23.
[22]刘长兴,郭心怡,王博宇,等.温阳化痰祛瘀法在老年不稳定型心绞痛中的应用[J].天津中医药大学学报,2025,44(4):299-302.
[23]雷龙鸣,王琼潇,程纬民.《黄帝内经》“阳化气，阴成形”的理论及应用研究[J].中华中医药杂志,2025,40(9):4399-4405.
[24]陈一帆,姜众会,王柳丁,等.基于“阳化气，阴成形”理论探析心肌梗死后心室重构的病机与治疗[J].中医杂志,2024,65(17):1762-1768.
[25]王敏,武蓓蓓,贺少君,等.基于“阳化气，阴成形”探讨益气通脉汤治疗不稳定型心绞痛的理论基础[J].上海中医药大学学报,2023,37(5):78-82.
[26]丹丹,李营,辛鑫,等.基于“阳化气，阴成形”探讨冠状动脉粥样硬化性心脏病的中医辨治[J].中国民间疗法,2022,30(7):14-16.
[27]彭艳斌,蔡虎志,陈青扬,等.从“阳化气阴成形”理论探讨枳实薤白桂枝汤治疗胸痹[J].陕西中医,2020,41(12):1787-1789.
[28]吴月蓉,王永,陈隽.从“痰瘀互结”角度探讨不稳定型心绞痛[J].中医药临床杂志,2025,37(12):2451-2454.
[29]李慧茹,王华.基于“阳化气，阴成形”理论探讨麝香保心丸治疗冠状动脉微循环障碍的施治方义[J].中西医结合心脑血管病杂志,2024,22(6):1143-1145.
[30]王倩,袁瑶,郭淑婷,等.从“阳化气，阴成形”论治微血管性心绞痛验案举隅[J].亚太传统医药,2025,21(4):92-95.
[31]马彦,项耀祖,王勇,等.胸痹心痛“痰瘀毒虚”病机演变[J].中西医结合研究,2026,18(3):220-225.
[32]王杰,张剑富,任星蓉,等.胸痹心痛病机演变发展[J].光明中医,2025,40(11):2222-2225.

相似文献/References:

[1]朱 薇.通脉调脂方治疗冠心病稳定性心绞痛疗效及对患者血流变、VCAM1〖JZ〗及ICAM1影响的研究*[J].陕西中医,2019,(3):290.
　ZHU Wei..Effect of Tongmai Tiaozhi recipe on the efficacy, Hemorheology, VCAM1 and ICAM1 〖JZ〗in patients with stable angina pectoris of coronary heart disease[J].,2019,(8):290.
[2]时晓华.丹参多酚酸盐注射液辅助介入治疗冠心病 及对患者心、肾功能和心肌损伤的影响*[J].陕西中医,2019,(5):568.
　SHI Xiaohua..Effects of salvianolate injection on cardiac function, renal function, myocardial injury in percutaneous coronary intervention postoperative patients with coronary heart disease[J].,2019,(8):568.
[3]刘 红,张玲燕,杨 玲.血府逐瘀汤治疗冠心病介入术后心绞痛临床研究[J].陕西中医,2019,(5):594.
　LIU Hong,ZHANG Lingyan,YANG Ling..Clinical observation of Xuefu Zhuyu decoction in the treatment of angina pectoris after PCI for coronary heart disease[J].,2019,(8):594.
[4]吕永飞,陈爱莲.益心康泰胶囊治疗冠心病经皮冠状动脉介入术术后疗效及对患者血流变、血管内皮功能的影响*[J].陕西中医,2019,(6):714.
　LV Yongfei,CHEN Ailian..Effect of Yixin Kangtai capsule on the curative effect hemorheology and vascular endothelial function after coronary artery disease PCI[J].,2019,(8):714.
[5]贺建涛,胡宇才,刘 磊.活血通络散治疗冠心病PCI术后心绞痛疗效研究*[J].陕西中医,2019,(7):854.
　HE Jiantao,HU Yucai,LIU Lei..Efficacy observation of Huoxue Tongluo powder in the treatment of angina pectoris after coronary heart disease PCI[J].,2019,(8):854.
[6]解洪涛,张 顺△,曾广伟.当归补血方联合西药治疗冠脉搭桥术后疗效及对患者血瘀证证候评分和凝血功能的影响*[J].陕西中医,2019,(10):1341.
　XIE Hongtao,ZHANG Shun,ZENG Guangwei..Effects of Danggui Buxue prescription combined with western medicine on blood stasis and coagulation function after coronary artery bypass grafting[J].,2019,(8):1341.
[7]索晓菲,王亚红△,王居新,等.软坚通脉汤治疗冠心病PCI术后Ⅱ期心脏康复疗效〖JZ〗及对患者生活质量的影响*[J].陕西中医,2020,(1):29.
[8]尹 毅,李小兰△.益气活血汤联合尼可地尔治疗稳定性心绞痛疗效及对患者T淋巴细胞亚群的影响[J].陕西中医,2020,(7):888.[doi:DOI:10.3969/j.issn.10007369.2020.07.014]
[9]季学清,刘 萍△,陈宝瑾,等.冠心康方加减联合西药治疗冠心病合并2型糖尿病气虚痰瘀证疗效研究*[J].陕西中医,2020,(9):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
　JI Xueqing,LIU Ping,CHEN Baojin,et al.Efficacy of Guanxinkang preparation combined with western medicine in the treatment of coronary heart disease and type 2 diabetes mellitus with syndrome of Qixu Tanyu[J].,2020,(8):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
[10]董其浩,邓 兵.益脉强心汤对冠心病合并心衰患者心室重构及血清血小板活化因子、转化生长因子-β1的影响[J].陕西中医,2021,(7):883.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.018]

备注/Memo

备注/Memo:
国家自然科学基金资助项目（81573941）；国家中医药管理局“胡国恒全国名老中医药专家传承工作室”建设项目（国中医药人教函〔2022〕75号）；国家中医药管理局“王行宽全国名中医传承工作室”建设项目（国中医药办人教函〔2018〕119号）；湖南省自然科学基金资助项目（2026JJ70067）；湖南中医药大学研究生创新课题（2023CX05）；湖南中医药大学中医学国内一流学科建设项目（湘教通〔2018〕469号）
更新日期/Last Update: 2026-08-13